| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study.
|
Circ Res
|
2005
|
3.20
|
|
2
|
Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial.
|
Circulation
|
2004
|
3.02
|
|
3
|
Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study.
|
Lancet Neurol
|
2011
|
2.84
|
|
4
|
qPET - a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma.
|
Eur J Nucl Med Mol Imaging
|
2014
|
2.51
|
|
5
|
New reference intervals for thyrotropin and thyroid hormones based on National Academy of Clinical Biochemistry criteria and regular ultrasonography of the thyroid.
|
Clin Chem
|
2005
|
2.24
|
|
6
|
Diverse functional properties of Wilson disease ATP7B variants.
|
Gastroenterology
|
2012
|
1.61
|
|
7
|
Correlation between automated writing movements and striatal dopaminergic innervation in patients with Wilson's disease.
|
J Neurol
|
2002
|
1.43
|
|
8
|
Serial 18F-fluoro-2-deoxy-D-glucose positron emission tomography and magnetic resonance imaging of paraneoplastic limbic encephalitis.
|
Arch Neurol
|
2004
|
1.40
|
|
9
|
[18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors.
|
Nucl Med Biol
|
2003
|
1.36
|
|
10
|
SNM practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT 1.0.
|
J Nucl Med
|
2011
|
1.28
|
|
11
|
Combined evaluation of FDG-PET and MRI improves detection and differentiation of dementia.
|
PLoS One
|
2011
|
1.24
|
|
12
|
Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies.
|
Neuroimage
|
2009
|
1.23
|
|
13
|
European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis.
|
Eur J Nucl Med Mol Imaging
|
2012
|
1.19
|
|
14
|
Summary report of the First International Workshop on PET/MR imaging, March 19-23, 2012, Tübingen, Germany.
|
Mol Imaging Biol
|
2013
|
1.10
|
|
15
|
Executive deficits are related to the inferior frontal junction in early dementia.
|
Brain
|
2011
|
1.09
|
|
16
|
Definition of primary and secondary glioblastoma--letter.
|
Clin Cancer Res
|
2014
|
1.09
|
|
17
|
PET quantification of 18F-florbetaben binding to β-amyloid deposits in human brains.
|
J Nucl Med
|
2013
|
1.08
|
|
18
|
Reduced alpha4beta2*-nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease.
|
Arch Gen Psychiatry
|
2009
|
1.08
|
|
19
|
Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer's disease and healthy controls.
|
Eur J Nucl Med Mol Imaging
|
2011
|
1.06
|
|
20
|
Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer's disease assessed with positron emission tomography.
|
Eur J Nucl Med Mol Imaging
|
2010
|
1.05
|
|
21
|
Meta-analysis based SVM classification enables accurate detection of Alzheimer's disease across different clinical centers using FDG-PET and MRI.
|
Psychiatry Res
|
2012
|
1.04
|
|
22
|
PET/MR in children. Initial clinical experience in paediatric oncology using an integrated PET/MR scanner.
|
Pediatr Radiol
|
2013
|
0.99
|
|
23
|
Value of semiquantitative analysis for clinical reporting of 123I-2-β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl)nortropane SPECT studies.
|
J Nucl Med
|
2013
|
0.98
|
|
24
|
Executive and behavioral deficits share common neural substrates in frontotemporal lobar degeneration - a pilot FDG-PET study.
|
Psychiatry Res
|
2010
|
0.96
|
|
25
|
Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: an overview of preclinical and clinical findings.
|
Psychopharmacology (Berl)
|
2011
|
0.96
|
|
26
|
Physical and organizational provision for installation, regulatory requirements and implementation of a simultaneous hybrid PET/MR-imaging system in an integrated research and clinical setting.
|
MAGMA
|
2012
|
0.95
|
|
27
|
Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder.
|
Psychiatry Res
|
2005
|
0.93
|
|
28
|
Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database.
|
Eur J Nucl Med Mol Imaging
|
2012
|
0.93
|
|
29
|
Reference cluster normalization improves detection of frontotemporal lobar degeneration by means of FDG-PET.
|
PLoS One
|
2013
|
0.93
|
|
30
|
Different mechanisms for changes in glucose uptake of the right and left ventricular myocardium in pulmonary hypertension.
|
J Nucl Med
|
2005
|
0.92
|
|
31
|
[18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphoma.
|
J Clin Oncol
|
2011
|
0.92
|
|
32
|
Florbetaben to trace amyloid-β in the Alzheimer brain by means of PET.
|
J Alzheimers Dis
|
2011
|
0.91
|
|
33
|
Residual lymph node metastasis in stage 4 neuroblastoma--advantage of radio-guided surgery?
|
Pediatr Hematol Oncol
|
2010
|
0.90
|
|
34
|
Measurement of the alpha4beta2* nicotinic acetylcholine receptor ligand 2-[(18)F]Fluoro-A-85380 and its metabolites in human blood during PET investigation: a methodological study.
|
Nucl Med Biol
|
2007
|
0.90
|
|
35
|
Effects of subthalamic nucleus stimulation on striatal dopaminergic transmission in patients with Parkinson's disease within one-year follow-up.
|
J Neurol
|
2008
|
0.89
|
|
36
|
Assessment of α7 nicotinic acetylcholine receptor availability in juvenile pig brain with [¹⁸F]NS10743.
|
Eur J Nucl Med Mol Imaging
|
2011
|
0.89
|
|
37
|
Concordant pre- and postsynaptic deficits of dopaminergic neurotransmission in neurologic Wilson disease.
|
AJNR Am J Neuroradiol
|
2003
|
0.89
|
|
38
|
No association between striatal dopamine transporter binding and body mass index: a multi-center European study in healthy volunteers.
|
Neuroimage
|
2012
|
0.89
|
|
39
|
Combined PET/MR: Where are we now? Summary report of the second international workshop on PET/MR imaging April 8-12, 2013, Tubingen, Germany.
|
Mol Imaging Biol
|
2014
|
0.88
|
|
40
|
Positron-emission tomography imaging in the diagnosis of bisphosphonate-related osteonecrosis of the jaw.
|
Oral Surg Oral Med Oral Pathol Oral Radiol Endod
|
2009
|
0.87
|
|
41
|
In vivo measurement of nicotinic acetylcholine receptors with [18F]norchloro-fluoro-homoepibatidine.
|
Synapse
|
2008
|
0.87
|
|
42
|
Dissociating behavioral disorders in early dementia-An FDG-PET study.
|
Psychiatry Res
|
2011
|
0.87
|
|
43
|
Dopamine transporter imaging in adult patients with attention-deficit/hyperactivity disorder.
|
Psychiatry Res
|
2009
|
0.87
|
|
44
|
Changes in myocardial perfusion due to physical exercise in patients with stable coronary artery disease.
|
Eur J Nucl Med Mol Imaging
|
2005
|
0.87
|
|
45
|
Dissociating memory networks in early Alzheimer's disease and frontotemporal lobar degeneration - a combined study of hypometabolism and atrophy.
|
PLoS One
|
2013
|
0.87
|
|
46
|
Neural correlates of the DemTect in Alzheimer's disease and frontotemporal lobar degeneration - A combined MRI & FDG-PET study.
|
Neuroimage Clin
|
2013
|
0.86
|
|
47
|
Developmental and amyloid plaque-related changes in cerebral cortical capillaries in transgenic Tg2576 Alzheimer mice.
|
Int J Dev Neurosci
|
2006
|
0.86
|
|
48
|
Investigating dopaminergic neurotransmission with 123I-FP-CIT SPECT: comparability of modern SPECT systems.
|
J Nucl Med
|
2003
|
0.85
|
|
49
|
Integrated PET/MRI for planning navigated biopsies in pediatric brain tumors.
|
Childs Nerv Syst
|
2014
|
0.85
|
|
50
|
Alterations in cholinergic and non-cholinergic neurotransmitter receptor densities in transgenic Tg2576 mouse brain with beta-amyloid plaque pathology.
|
Int J Dev Neurosci
|
2003
|
0.85
|
|
51
|
Reduced serotonin transporter-availability in obsessive-compulsive disorder (OCD).
|
Eur Arch Psychiatry Clin Neurosci
|
2004
|
0.85
|
|
52
|
Preoperative mapping of cortical language areas in adult brain tumour patients using PET and individual non-normalised SPM analyses.
|
Eur J Nucl Med Mol Imaging
|
2003
|
0.85
|
|
53
|
Radiosynthesis of racemic and enantiomerically pure (-)-[18F]flubatine--a promising PET radiotracer for neuroimaging of α4β2 nicotinic acetylcholine receptors.
|
Appl Radiat Isot
|
2013
|
0.84
|
|
54
|
Influence of scan duration on the accuracy of β-amyloid PET with florbetaben in patients with Alzheimer's disease and healthy volunteers.
|
Eur J Nucl Med Mol Imaging
|
2012
|
0.84
|
|
55
|
Imaging of the brain serotonin transporters (SERT) with 18F-labelled fluoromethyl-McN5652 and PET in humans.
|
Eur J Nucl Med Mol Imaging
|
2012
|
0.83
|
|
56
|
Imaging the Alzheimer brain.
|
J Alzheimers Dis
|
2011
|
0.83
|
|
57
|
Is correction for age necessary in neuroimaging studies of the central serotonin transporter?
|
Eur J Nucl Med Mol Imaging
|
2003
|
0.83
|
|
58
|
Relative quantification of indium-111 pentetreotide and gallium-68 DOTATOC uptake in the thyroid gland and association with thyroid pathologies.
|
Thyroid
|
2009
|
0.83
|
|
59
|
Neuroimaging of the vesicular acetylcholine transporter by a novel 4-[18F]fluoro-benzoyl derivative of 7-hydroxy-6-(4-phenyl-piperidin-1-yl)-octahydro-benzo[1,4]oxazines.
|
Nucl Med Biol
|
2009
|
0.83
|
|
60
|
Synthesis of novel 4- and 5-substituted benzyl ether derivatives of vesamicol and in vitro evaluation of their binding properties to the vesicular acetylcholine transporter site.
|
Bioorg Med Chem
|
2004
|
0.83
|
|
61
|
Monoamine transporter availability in Parkinson's disease patients with or without depression.
|
Eur J Nucl Med Mol Imaging
|
2008
|
0.82
|
|
62
|
The role of positron emission tomography imaging in understanding Alzheimer's disease.
|
Expert Rev Neurother
|
2015
|
0.82
|
|
63
|
The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder.
|
Int J Neuropsychopharmacol
|
2011
|
0.82
|
|
64
|
Perspectives for multimodal neurochemical and imaging biomarkers in Alzheimer's disease.
|
J Alzheimers Dis
|
2013
|
0.82
|
|
65
|
Diagnostics of cerebral gliomas with radiolabeled amino acids.
|
Dtsch Arztebl Int
|
2008
|
0.82
|
|
66
|
No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [123I]FP-CIT (DaTSCAN) and SPECT.
|
EJNMMI Res
|
2013
|
0.81
|
|
67
|
Enhanced catecholamine transporter binding in the locus coeruleus of patients with early Parkinson disease.
|
BMC Neurol
|
2011
|
0.81
|
|
68
|
Molecular imaging of alpha7 nicotinic acetylcholine receptors: design and evaluation of the potent radioligand [18F]NS10743.
|
Eur J Nucl Med Mol Imaging
|
2009
|
0.81
|
|
69
|
Sentinel lymph node biopsy in squamous cell carcinomas of the lips and the oral cavity - a single center experience.
|
J Surg Oncol
|
2007
|
0.81
|
|
70
|
Fully automated radiosynthesis of both enantiomers of [18F]Flubatine under GMP conditions for human application.
|
Appl Radiat Isot
|
2013
|
0.81
|
|
71
|
Thyroid volume measurement in patients prior to radioiodine therapy: comparison between three-dimensional magnetic resonance imaging and ultrasonography.
|
Thyroid
|
2002
|
0.81
|
|
72
|
Ethnic comparison of pharmacokinetics of (18)F-florbetaben, a PET tracer for beta-amyloid imaging, in healthy Caucasian and Japanese subjects.
|
Eur J Nucl Med Mol Imaging
|
2014
|
0.80
|
|
73
|
Cerebral correlates of selective attention in schizophrenic patients with formal thought disorder: a controlled H2 15O-PET study.
|
Psychiatry Res
|
2002
|
0.80
|
|
74
|
A new 18F-labeled fluoroacetylmorpholino derivative of vesamicol for neuroimaging of the vesicular acetylcholine transporter.
|
Nucl Med Biol
|
2008
|
0.80
|
|
75
|
Preserved serotonin transporter binding in de novo Parkinson's disease: negative correlation with the dopamine transporter.
|
J Neurol
|
2010
|
0.80
|
|
76
|
Synthesis procedure for routine production of 2-[18F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-[18F]F-A-85380).
|
Appl Radiat Isot
|
2007
|
0.79
|
|
77
|
Kinetic analyses of [123I]IBZM SPECT for quantification of striatal dopamine D2 receptor binding: a critical evaluation of the single-scan approach.
|
Neuroimage
|
2008
|
0.79
|
|
78
|
Autoradiography of 2-[18F]F-A-85380 on nicotinic acetylcholine receptors in the porcine brain in vitro.
|
Synapse
|
2006
|
0.78
|
|
79
|
Lean body mass correction of standardized uptake value in simultaneous whole-body positron emission tomography and magnetic resonance imaging.
|
Phys Med Biol
|
2015
|
0.78
|
|
80
|
Advances in in vivo imaging of serotonergic neurons in neuropsychiatric disorders.
|
Neurosci Biobehav Rev
|
2004
|
0.78
|
|
81
|
Binding properties of the cerebral alpha4beta2 nicotinic acetylcholine receptor ligand 2-[18F]fluoro-A-85380 to plasma proteins.
|
Nucl Med Biol
|
2006
|
0.78
|
|
82
|
Effect of progenitor cells on myocardial perfusion and metabolism in patients after recanalization of a chronically occluded coronary artery.
|
J Nucl Med
|
2008
|
0.78
|
|
83
|
Evaluation of the sensitivity of the novel α4β2* nicotinic acetylcholine receptor PET radioligand 18F-(-)-NCFHEB to increases in synaptic acetylcholine levels in rhesus monkeys.
|
Synapse
|
2014
|
0.77
|
|
84
|
Effect of drug-induced cytotoxicity on glucose uptake in Hodgkin's lymphoma cells.
|
Eur J Haematol
|
2006
|
0.77
|
|
85
|
Visualization of ectopic parathyroid adenomas.
|
N Engl J Med
|
2013
|
0.77
|
|
86
|
Impact of EEG-vigilance on brain glucose uptake measured with [(18)F]FDG and PET in patients with depressive episode or mild cognitive impairment.
|
Neuroimage
|
2011
|
0.77
|
|
87
|
Altered serotonin transporter availability in patients with multiple sclerosis.
|
Eur J Nucl Med Mol Imaging
|
2014
|
0.77
|
|
88
|
Pyrrolovesamicols--synthesis, structure and VAChT binding of two 4-fluorobenzoyl regioisomers.
|
Bioorg Med Chem Lett
|
2012
|
0.77
|
|
89
|
Serotonin transporter imaging with [123I]beta-CIT SPECT before and after one year of citalopram treatment of obsessive-compulsive disorder.
|
Neuropsychobiology
|
2006
|
0.76
|
|
90
|
Structural changes of benzylether derivatives of vesamicol and their influence on the binding selectivity to the vesicular acetylcholine transporter.
|
Eur J Med Chem
|
2005
|
0.76
|
|
91
|
Comments on Eusebio et al.: Voxel-based analysis of whole-brain effects of age and gender on dopamine transporter SPECT imaging in healthy subjects.
|
Eur J Nucl Med Mol Imaging
|
2012
|
0.75
|
|
92
|
Thoracic [18F]fluorodeoxyglucose uptake measured by positron emission tomography/computed tomography in pulmonary hypertension.
|
Medicine (Baltimore)
|
2016
|
0.75
|
|
93
|
123I-beta-CIT SPECT for imaging serotonin transporters in Parkinson's disease.
|
J Nucl Med
|
2004
|
0.75
|
|
94
|
Robust, fully automatic delineation of the head contour by stereotactical normalization for attenuation correction according to Chang in dopamine transporter scintigraphy.
|
Eur Radiol
|
2015
|
0.75
|
|
95
|
[46th Congress of the German Society of Nuclear Medicine. Introduction].
|
Nuklearmedizin
|
2008
|
0.75
|
|
96
|
Preoperative mapping of cortical motor function: prospective comparison of functional magnetic resonance imaging and [15O]-H2O-positron emission tomography in the same co-ordinate system.
|
Nucl Med Commun
|
2004
|
0.75
|
|
97
|
[Multilocular osteo-articular pain combined with pustular skin eruptions in an adolescent].
|
J Dtsch Dermatol Ges
|
2008
|
0.75
|
|
98
|
Heart abscess revealed by nuclear medicine imaging.
|
Eur J Nucl Med Mol Imaging
|
2005
|
0.75
|
|
99
|
Simultaneous osteosarcoma and papillary thyroid carcinoma.
|
Lancet Oncol
|
2005
|
0.75
|
|
100
|
Preoperative brain mapping using [15O]water activation PET provides evidence on altered language networks in an adult brain tumour patient.
|
Eur J Nucl Med Mol Imaging
|
2002
|
0.75
|
|
101
|
Effects of left ventricular volume and ejection on myocardial blood flow measured by oxygen-15 water positron emission tomography in coronary heart disease.
|
Am J Cardiol
|
2003
|
0.75
|
|
102
|
[German Society of Nuclear Medicine procedure guideline on beta-amyloid brain PET imaging].
|
Nuklearmedizin
|
2016
|
0.75
|